GGIDX
Price
$13.41
Change
-$0.05 (-0.37%)
Updated
Jun 3 closing price
Net Assets
100.84M
RGFTX
Price
$10.27
Change
-$0.03 (-0.29%)
Updated
Jun 3 closing price
Net Assets
365.92M
Interact to see
Advertisement

GGIDX vs RGFTX

Header iconGGIDX vs RGFTX Comparison
Open Charts GGIDX vs RGFTXBanner chart's image
Goldman Sachs Global Infras Instl
Price$13.41
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets100.84M
Russell Inv Global Infrastructure M
Price$10.27
Change-$0.03 (-0.29%)
VolumeN/A
Net Assets365.92M
GGIDX vs RGFTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGIDX vs. RGFTX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGIDX is a Buy and RGFTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGFTX has more cash in the bank: 366M vs. GGIDX (101M). RGFTX pays higher dividends than GGIDX: RGFTX (2.69) vs GGIDX (2.11). GGIDX was incepted earlier than RGFTX: GGIDX (9 years) vs RGFTX (8 years). RGFTX (1.24) and GGIDX (1.23) have similar cost to investors . RGFTX is a more actively managed with annual turnover of: 67.00 vs. GGIDX (32.00). RGFTX has a lower initial minimum investment than GGIDX: RGFTX (0) vs GGIDX (1000000). RGFTX annual gain was more profitable for investors over the last year : 17.71 vs. GGIDX (9.27). GGIDX (22.42) and RGFTX (21.51) have equivalent 5 years return.
GGIDXRGFTXGGIDX / RGFTX
Total Expense Ratio0.970.91107%
Annual Report Gross Expense Ratio1.231.2499%
Fund Existence9 years8 years-
Gain YTD12.86114.30790%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets101M366M28%
Annual Yield % from dividends2.112.6979%
Returns for 1 year9.2717.7152%
Returns for 3 years2.9516.9517%
Returns for 5 years22.4221.51104%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.95N/A
N/A
Saratoga Health & Biotechnology A
MSAAX18.95N/A
N/A
Morgan Stanley Inst Passport ovrs eq C
RGPAX21.85N/A
N/A
RBC Global Opportunities A
WSTRX47.38N/A
N/A
Macquarie Science and Technology R
CLCRX22.28N/A
N/A
Columbia Select Large Cap Equity Inst2